Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 · New England Journal of Medicine · 1,135 citations
https://doi.org/10.1056/nejmoa1413687
J
Jean‐Luc Vachiéry
Erasmus Hospital(BE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
234
Papers
10.1K
Citations
41
h-index
98
i10-index
Jean‐Luc Vachiéry is an academic researcher from Erasmus Hospital. The author has contributed to research in topics: Pulmonary Hypertension Research and Treatments & Cardiovascular Function and Risk Factors & Heart Failure Treatment and Management. The author has an h-index of 41, co-authored 199 publications.
Papers by this author
worksInternational Guidelines for the Selection of Lung Transplant Candidates: 2006 Update—A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation
2006 · The Journal of Heart and Lung Transplantation · 1,084 citations
https://doi.org/10.1016/j.healun.2006.03.011
Left ventricular heart failure and pulmonary hypertension
2015 · European Heart Journal · 676 citations
https://doi.org/10.1093/eurheartj/ehv512
Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial
2018 · The Journal of Heart and Lung Transplantation · 28 citations
https://doi.org/10.1016/j.healun.2018.11.006
The linear relationship between systolic pulmonary artery pressure and mean pulmonary artery pressure is maintained regardless of autonomic or rhythm disturbances
2016 · Respiratory Research · 10 citations
https://doi.org/10.1186/s12931-016-0350-7
Improvement in right ventricular function during reversibility testing in pulmonary arterial hypertension: a case report
2009 · Cardiovascular Ultrasound · 9 citations
https://doi.org/10.1186/1476-7120-7-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat